Added to YB: 2019-12-13
Pitch date: 2019-12-13
NBIX [bearish]
Neurocrine Biosciences, Inc.
-17.58%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.
Market Cap
$12.8B
Pitch Price
$110.65
Price Target
N/A
Dividend
N/A
EV/EBITDA
16.23
P/E
27.36
EV/Sales
4.13
Sector
Biotechnology
Category
N/A
Show full summary:
NEUROCRINE BIOSCIENCES INC NBIX
A summary for this pitch has not been created yet.
Read full article (0 min)